Evolutec: A Ticktastic Biotech

The problem we have got now is all the small T10 investors who are deciding to sell. We still have trial results to be released in January which even if bad can't see this go much lower given the very low current market cap. If they are good or even average then this will go much much higher. Pays your money takes your choice.
There still haven't been any large selling over the past three weeks so alot of institutions must still be holding waiting for news. I am happy to sit this one out at then end of the day its only a paper loss, not real until you sell.
Good luck everyone.